The company was founded by experts in the fields of galectin-3 biology, cardiovascular pharmaceutical development, and carbohydrate drug synthesis and manufacturing. Their galectin-3 research has been cited over 2,000 times in scientific literature, highlighting the importance of their studies. G3 Pharmaceuticals partners with scientists and clinicians worldwide to advance the understanding of galectin-3 and develops proprietary carbohydrate inhibitors for pharmaceutical development. The company also investigates the role of galectin-3 in heart, kidney, and lung disease to identify the patients who are most likely to benefit from their inhibitors when they are ready for clinical testing. G3 Pharmaceuticals is located in Lexington, Massachusetts.